These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689 [TBL] [Abstract][Full Text] [Related]
23. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P; Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260 [TBL] [Abstract][Full Text] [Related]
24. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030 [TBL] [Abstract][Full Text] [Related]
25. One year continuous run with a totally implantable insulin infusion pump in a human diabetic. Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734 [No Abstract] [Full Text] [Related]
26. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D; JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453 [TBL] [Abstract][Full Text] [Related]
27. Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapy. Moreno-Fernandez J; Chico A; Endocrinol Nutr; 2016 Dec; 63(10):571-572. PubMed ID: 27765489 [No Abstract] [Full Text] [Related]
28. Sensor-augmented insulin-pump therapy in type 1 diabetes. Diamant M N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396 [No Abstract] [Full Text] [Related]
29. A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. Raskin P; Holcombe JH; Tamborlane WV; Malone JI; Strowig S; Ahern JA; Lavent F J Diabetes Complications; 2001; 15(6):295-300. PubMed ID: 11711322 [TBL] [Abstract][Full Text] [Related]
30. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Nixon R; Folwell R; Pickup JC Diabet Med; 2014 Oct; 31(10):1174-7. PubMed ID: 24804864 [TBL] [Abstract][Full Text] [Related]
31. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes. Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236 [TBL] [Abstract][Full Text] [Related]
32. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Tsui E; Barnie A; Ross S; Parkes R; Zinman B Diabetes Care; 2001 Oct; 24(10):1722-7. PubMed ID: 11574432 [TBL] [Abstract][Full Text] [Related]
33. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes. Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814 [TBL] [Abstract][Full Text] [Related]
34. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes. Kekäläinen P; Juuti M; Walle T; Laatikainen T Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287 [TBL] [Abstract][Full Text] [Related]
35. When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump. Cohen O; Filetti S; Castañeda J; Maranghi M; Glandt M Diabetes Care; 2016 Aug; 39 Suppl 2():S180-6. PubMed ID: 27440831 [TBL] [Abstract][Full Text] [Related]
36. [Better diabetic control with a 4-dose regime--the insulin pen makes the change easier]. Johannsson G; Stenström G; Fahl H; Andersson AG; Fors B Lakartidningen; 1991 Mar; 88(11):954, 957, 959-60. PubMed ID: 2008146 [No Abstract] [Full Text] [Related]
37. Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison. Zisser H; Wagner R; Pleus S; Haug C; Jendrike N; Parkin C; Schweitzer M; Freckmann G Diabetes Technol Ther; 2010 Dec; 12(12):955-61. PubMed ID: 21128842 [TBL] [Abstract][Full Text] [Related]
38. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study. Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604 [TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Rizvi AA; Petry R; Arnold MB; Chakraborty M Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372 [TBL] [Abstract][Full Text] [Related]
40. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study. Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]